Home         Health Tips  
Career Contact Us Sitemap
About Us        Products         Services         Pharmacies         News & Events
Autoimmune Diagnostics
ProductsHumanAutoimmune DiagnosticsLiver
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------


  Liver

Autoimmune liver diseases include autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) and overlap syndromes among these disorders.

In approximately 98% of AIH patients, antinuclear antibodies (ANA) can be found either in isolation or in combination with antibodies against:
¤ smooth muscles (SMA).
¤ actin epitopes.
¤ liver-kidney microsomes (anti-LKM1).
¤ liver-pancreas-specific or soluble liver antigen (Anti-LP/SLA). Typical for AIH.
¤ is also the increase of serum IgG globulins.

PBC is characterized by the presence of antimitochondrial anti-M2 antibodies, which target the antigen alpha-ketoacid dehydrogenase complex of the inner mitochondrial membrane. The antibodies are detectable in 95% of patients. In the rare anti-M2-negative PBC patients, other PBC-specific antibodies can usually be detected (eg. antibodies against “nuclear dots” (anti-SP100), centromere or nuclear membrane). The increase of serum IgM globulins is a characteristic of PBC.

In PSC, although antibodies against granulocytes (pANCA) are described these are only present in about 70% of PSC-positive patients and - depending on the method - are even detectable in autoimmune hepatitis and vasculitis. The diagnosis must therefore focus primarily on the detection of intra-or extrahepatic bile duct changes by ERCP.

The detection of specific autoantibody profiles in patients with an unclear chronic liver disease diagnosis is therefore useful for the early diagnosis of an autoimmune process, and often also allows the discrimination between infectious and toxic processes.

For more information, please select from the following list:

IMTEC-Liver Screen S

ELISA for the Quantitative Determination of Antibodies in Autoimmune Liver Diseases (IgG) | 96 Tests.

ITC66005
  IMTEC-Liver Profile S

ELISA for the Quantitative Determination of Antibodies in Autoimmune Liver Diseases (IgG) | 96 Tests.

ITC66105
  IMTEC-AMA M2

ELISA for the Quantitative Determination of Anti-mitochondrial-Antibodies M2 (IgG) | 96 Tests.

ITC60040
  IMTEC-Sp100-Antibodies

ELISA for the Quantitative Determination of Anti-SP100-Antibodies (IgG) | 96 Tests.

ITC66040


IMTEC-LKM1-Antibodies

ELISA for the Quantitative Determination of Anti-LKM1-Antibodies (IgG) | 96 Tests.

ITC66050
  IMTEC-SLA-Antibodies (cut-off)

ELISA for the Detection of Anti-SLA-Antibodies (IgG) | 96 Tests.

ITC66060
  IMTEC-Liver-LIA S

Line Immuno Assay (LIA) for the Detection of Autoantibodies in autoimmunen Liver Diseases (AMA M2, Sp100, LKM1, gp210, LC1, SLA) | 24 Tests.

ITC66205
   
 
 
 

HOME
ABOUT US
SERVICES
PHARMACIES
NEWS & Events

PRODUCTS
Human
Nidacon
Rocket Medical
Star Diagnostics
JS Reasearch
Shandong
Scientific & Educational

HEALTH TIPS
CAREER
CONTACT US
SITEMAP
PRIVACY POLICY